Identification and characterization of mechanistically distinct inducers of γ-globin transcription

[1]  G. Stamatoyannopoulos,et al.  FKLF-2: a novel Krüppel-like transcriptional factor that activates globin and other erythroid lineage genes. , 2000, Blood.

[2]  K. Wood,et al.  Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.

[3]  A. Schechter,et al.  Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia. , 1993, Blood.

[4]  S. Jane,et al.  Induction of Human Fetal Globin Gene Expression by a Novel Erythroid Factor, NF-E4 , 2000, Molecular and Cellular Biology.

[5]  A. Schechter,et al.  Levels of fetal hemoglobin necessary for treatment of sickle cell disease. , 1988, The New England journal of medicine.

[6]  A. Nienhuis,et al.  Human globin gene promoter sequences are sufficient for specific expression of a hybrid gene transfected into tissue culture cells , 1987, Molecular and cellular biology.

[7]  B. Pace,et al.  Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors , 2000, American journal of hematology.

[8]  V. Ingram,et al.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.

[9]  M. Vidal,et al.  A dominant control region from the human β-globin locus conferring integration site-independent gene expression , 1989, Nature.

[10]  M. Crossley,et al.  Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors. , 1999, The international journal of biochemistry & cell biology.

[11]  A. Nienhuis,et al.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. , 1990, Nucleic acids research.

[12]  M L Terrin,et al.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.

[13]  Joo-In Park,et al.  Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  Peter Fraser,et al.  Transcription complex stability and chromatin dynamics in vivo , 1995, Nature.

[15]  G. Kollias,et al.  Regulated expression of human A gamma-, beta-, and hybrid gamma beta-globin genes in transgenic mice: manipulation of the developmental expression patterns. , 1986, Cell.

[16]  M. Goodman,et al.  Evolutionary strategies for the elucidation of cis and trans factors that regulate the developmental switching programs of the beta-like globin genes. , 1996, Molecular phylogenetics and evolution.

[17]  D. Zwiers,et al.  5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D M Schmatz,et al.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. J. Browne,et al.  Genomes, molecular biology and drug discovery , 1996 .

[20]  H. W. Lee,et al.  Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. , 2000, Cancer research.

[21]  G. Stamatoyannopoulos,et al.  Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. , 1999, Blood.

[22]  A. Schechter,et al.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Nienhuis,et al.  The upstream region of the human gamma-globin gene promoter. Identification and functional analysis of nuclear protein binding sites. , 1991, The Journal of biological chemistry.

[24]  F. Collins,et al.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin , 1988, Molecular and cellular biology.

[25]  W. Wood.  The complexities of beta globin gene regulation. , 1996, Trends in genetics : TIG.

[26]  D. Tuan,et al.  The "beta-like-globin" gene domain in human erythroid cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Wei Zhu,et al.  Evolutionary Strategies for the Elucidation ofcisandtransFactors That Regulate the Developmental Switching Programs of the β-like Globin Genes , 1996 .

[28]  O. Witt,et al.  Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. , 2003, Blood.

[29]  S. Jane,et al.  Identification of Id2 as a Globin Regulatory Protein by Representational Difference Analysis of K562 Cells Induced To Express γ-Globin with a Fungal Compound , 1999, Molecular and Cellular Biology.

[30]  G. Kollias,et al.  Position-independent, high-level expression of the human β-globin gene in transgenic mice , 1987, Cell.

[31]  R. Hoffman,et al.  2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. , 2000, Blood.

[32]  G. Kollias,et al.  Regulated expression of human A γ-, β-, and hybrid γβ-globin genes in transgenic mice: Manipulation of the developmental expression patterns , 1986, Cell.

[33]  J. D. Engel,et al.  Biochemical characterization of the developmental stage- and tissue-specific erythroid transcription factor, NF-E4. , 1994, Journal of Biological Chemistry.

[34]  B. Pace,et al.  Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. , 2002, Blood.

[35]  P. Talalay,et al.  Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  N. Holbrook,et al.  Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. , 1992, Cancer research.

[37]  A. Schechter,et al.  The impact of molecular biology on the diagnosis and treatment of hemoglobin disorders. , 1992, Molecular genetic medicine.

[38]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .

[39]  J. Clegg,et al.  Thalassemia and malaria: new insights into an old problem. , 1999, Proceedings of the Association of American Physicians.

[40]  F. Costantini,et al.  Specific expression of a foreign β-globin gene in erythroid cells of transgenic mice , 1985, Nature.

[41]  Arthur W. Nienhuis,et al.  Hemoglobin switching , 1978, Cell.

[42]  A. Schechter,et al.  Inhibition of Sickle Hemoglobin Polymerization as a Basis for Therapeutic Approaches to Sickle‐Cell Anemia , 2003 .

[43]  S. Jane,et al.  Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. , 1995, The EMBO journal.

[44]  W. Wood.  The complexities of β globin gene regulation , 1996 .

[45]  R. Morimoto,et al.  Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. , 1988, Molecular and cellular biology.

[46]  G. Stamatoyannopoulos,et al.  FKLF, a Novel Krüppel-Like Factor That Activates Human Embryonic and Fetal β-Like Globin Genes , 1999, Molecular and Cellular Biology.

[47]  F. Costantini,et al.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice , 1986, Nature.